{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:39Z","timestamp":1790224479705,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtho.2022.10.016","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T13:43:27Z","timestamp":1667569407000},"page":"299-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review"],"prefix":"10.1016","volume":"18","author":[{"given":"Conrad B.","family":"Falkson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily T.","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Maziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee C.","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2022.10.016_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","article-title":"Thymic neuroendocrine tumors: a SEER database analysis of 160 patients","volume":"251","author":"Gaur","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib4","series-title":"World Health Organization Classification of Tumours","article-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"issue":"suppl 4","key":"10.1016\/j.jtho.2022.10.016_bib5","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0003-4975(01)03032-6","article-title":"Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study","volume":"72","author":"Gal","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0022-5223(03)00798-0","article-title":"Thymoma: a clinicopathologic study based on the new World Health Organization classification","volume":"126","author":"Nakagawa","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejcts.2004.04.041","article-title":"Long-term survival and prognostic factors in thymic epithelial tumours","volume":"26","author":"Rea","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard","year":"1996","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/JTO.0b013e3181a4b8e0","article-title":"The management of thymoma: a systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","article-title":"Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors","volume":"9","author":"Huang","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2022.10.016_bib14","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/JTO.0000000000000303","article-title":"The IASLC\/ITMIG thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Nicholson","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib15","doi-asserted-by":"crossref","unstructured":"Falkson C, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline. J Thorac Oncol. 2022;17:1258-1275. https:\/\/doi.org\/10.1016\/j.jtho.2022.08.007","DOI":"10.1016\/j.jtho.2022.08.007"},{"key":"10.1016\/j.jtho.2022.10.016_bib16","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jtho.2022.10.016_bib17","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtho.2022.10.016_bib18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtho.2022.10.016_bib19","series-title":"Review Manager (RevMan) [Computer Program]. Version 5.4","year":"2020"},{"key":"10.1016\/j.jtho.2022.10.016_bib20","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.jtho.2022.10.016_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtho.2022.10.016_bib22","first-page":"136","article-title":"Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases","volume":"112","author":"Zhang","year":"1999","journal-title":"Chin Med J (Engl)"},{"issue":"suppl","key":"10.1016\/j.jtho.2022.10.016_bib23","doi-asserted-by":"crossref","first-page":"E492","DOI":"10.1016\/j.ijrobp.2019.06.1397","article-title":"THYPORT: postoperative radiotherapy versus surgery alone in Masaoka Stage II thymoma: mid-term result of a prospective randomized study from a Single Center(NCT02014805)","volume":"105","author":"Zhai","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ejcts\/ezaa362","article-title":"Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: analysis of a Japanese multi-institutional retrospective database","volume":"59","author":"Hishida","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2016.06.021","article-title":"Limited thymectomy as a potential alternative treatment option for early-stage thymoma: a multi-institutional propensity-matched study","volume":"101","author":"Narm","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1759-7714.12542","article-title":"Is thymomectomy sufficient for non-myasthenic early stage thymoma patients? A retrospective, single center experience","volume":"9","author":"Rusidanmu","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib27","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jtcvs.2014.01.029","article-title":"Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma","volume":"148","author":"Sakamaki","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/1759-7714.13059","article-title":"Nomogram to predict thymoma prognosis: a population-based study of 1312 cases","volume":"10","author":"Zhao","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.lungcan.2009.08.001","article-title":"Limited thymectomy for stage I or II thymomas","volume":"68","author":"Onuki","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.athoracsur.2015.07.084","article-title":"Is thymomectomy alone appropriate for stage I (T1N0M0) thymoma? Results of a propensity-score analysis","volume":"101","author":"Nakagawa","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib31","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.21037\/jtd.2017.09.109","article-title":"Could thymomectomy be a reasonable option for non-myasthenic thymoma patients?","volume":"9","author":"Tassi","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/JTO.0b013e31828cb3c2","article-title":"Is thymectomy necessary in nonmyasthenic patients with early thymoma?","volume":"8","author":"Tseng","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.athoracsur.2017.03.054","article-title":"Video-assisted thoracic surgery thymectomy versus sternotomy thymectomy in patients with thymoma","volume":"104","author":"Agatsuma","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib34","first-page":"21922","article-title":"Efficacy and safety of video-assisted thoracic surgery and median sternotomy in the treatment of thymoma-associated myasthenia gravis","volume":"9","author":"He","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jtho.2022.10.016_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0218492318778634","article-title":"Long-term survival after R0 resection of thymoma","volume":"26","author":"Kocer","year":"2018","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.jtho.2022.10.016_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1245\/s10434-013-3228-7","article-title":"Video-assisted thoracoscopic surgical thymectomy to treat early thymoma: a comparison with the conventional transsternal approach","volume":"21","author":"Liu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib37","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1093\/ejcts\/ezu077","article-title":"Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma","volume":"45","author":"Manoly","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib38","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/1759-7714.13464","article-title":"Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience","volume":"11","author":"Tian","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ciresp.2014.02.021","article-title":"An\u00e1lisis comparativo del abordaje para el tratamiento del timoma estadio i-ii: VATS versus abordaje convencional [Comparative analysis of video-assisted thoracic surgery versus open resection for early-stage thymoma]","volume":"93","author":"Trivi\u00f1o","year":"2015","journal-title":"Cir Esp"},{"key":"10.1016\/j.jtho.2022.10.016_bib40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jtcvs.2019.11.114","article-title":"A\u00a0national analysis of open versus minimally invasive thymectomy for stage I to III thymoma","volume":"160","author":"Yang","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/icvts\/ivaa133","article-title":"Perioperative risk factors for occurrence of myasthenia gravis after thymectomy in patients with thymoma","volume":"31","author":"Zhang","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/icvts\/ivx048","article-title":"Thoracoscopic thymectomy is a feasible and less invasive alternative for the surgical treatment of large thymomas","volume":"25","author":"Odaka","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40880-017-0213-8","article-title":"Long-term outcomes of 307 patients after complete thymoma resection","volume":"36","author":"Yuan","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.athoracsur.2012.04.097","article-title":"Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients","volume":"94","author":"Jurado","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib45","first-page":"741","article-title":"Single-center retrospective analysis of 162 cases with thymoma complicating myasthenia gravis","volume":"22","author":"Lin","year":"2017","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.jtho.2022.10.016_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ejcts\/ezy075","article-title":"Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study","volume":"54","author":"Marulli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amsu.2018.12.005","article-title":"Thoracoscopic thymectomy - the method of choise in surgical treatment of non-invasive thymomas","volume":"42","author":"Allakhverdiev","year":"2018","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jtho.2022.10.016_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0037-1604205","article-title":"Propensity score adjusted comparison of minimally invasive versus open thymectomy in the management of early stage thymoma","volume":"66","author":"Fadayomi","year":"2018","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib49","first-page":"62","article-title":"Surgical approaches for stage I and II thymoma-associated myasthenia gravis: feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy in comparison with trans-sternal resection","volume":"27","author":"He","year":"2013","journal-title":"J\u00a0Biomed Res"},{"key":"10.1016\/j.jtho.2022.10.016_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0034-1396594","article-title":"Long-term outcome for early stage thymoma: comparison between thoracoscopic and open approaches","volume":"63","author":"Maniscalco","year":"2015","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib51","first-page":"28","article-title":"Application of video-assisted thoracic surgery in the standard operation for thoracic tumors","volume":"10","author":"Mu","year":"2013","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jtho.2022.10.016_bib52","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/ejcts\/ezv380","article-title":"Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database","volume":"49","author":"Nakajima","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00464-013-3137-7","article-title":"Surgical treatment of early-stage thymomas: robot-assisted thoracoscopic surgery versus transsternal thymectomy","volume":"28","author":"Ye","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jtho.2022.10.016_bib54","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1245\/s10434-014-4068-9","article-title":"Long-term outcomes after thoracoscopic resection of stage I and II thymoma: A propensity-matched study","volume":"22","author":"Chao","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib55","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1378\/chest.128.4.3010","article-title":"Videothoracoscopic resection of stage II thymoma: prospective comparison of the results between thoracoscopy and open methods","volume":"128","author":"Cheng","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2022.10.016_bib56","first-page":"1973","article-title":"Long-term results of thoracoscopic thymectomy for thymoma without myasthenia gravis","volume":"40","author":"Chung","year":"2012","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jtho.2022.10.016_bib57","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1093\/ejcts\/ezt305","article-title":"The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas","volume":"44","author":"Kimura","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejcts.2009.10.003","article-title":"Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma","volume":"37","author":"Odaka","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib59","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/1759-7714.13396","article-title":"Surgical effect and prognostic factors of myasthenia gravis with thymomas","volume":"11","author":"Tian","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib60","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00595-013-0829-5","article-title":"Thoracoscopic versus transsternal resection for early stage thymoma: long-term outcomes","volume":"44","author":"Tagawa","year":"2014","journal-title":"Surg Today"},{"key":"10.1016\/j.jtho.2022.10.016_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ejcts\/ezu368","article-title":"Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients","volume":"48","author":"Guerrera","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib62","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.21037\/jtd.2020.02.63","article-title":"Does size matter? A national analysis of the utility of induction therapy for large thymomas","volume":"12","author":"Liou","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.athoracsur.2015.04.059","article-title":"Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database","volume":"100","author":"Yamada","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.athoracsur.2018.08.037","article-title":"Clinicopathologic features of thymoma with the expression of programmed death ligand 1","volume":"107","author":"Hakiri","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s13193-020-01215-2","article-title":"Surgical and oncological outcomes in locally advanced thymoma","volume":"12","author":"Kumar","year":"2021","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib66","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.21037\/jtd-20-1713","article-title":"The role of postoperative radiotherapy in stage II and III thymoma: a Korean multicenter database study","volume":"12","author":"Song","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib67","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.18632\/oncotarget.24315","article-title":"Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study","volume":"9","author":"Bian","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2022.10.016_bib68","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fonc.2019.01055","article-title":"Clinicopathologic significance and immunogenomic analysis of programmed death-ligand 1 (PD-L1) and programmed death 1 (PD-1) expression in thymic epithelial tumors","volume":"9","author":"Song","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1556-0864(15)31586-0","article-title":"Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up","volume":"1","author":"Lucchi","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lungcan.2010.07.006","article-title":"Multidisciplinary approach for advanced stage thymic tumors: long-term outcome","volume":"72","author":"Rea","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.athoracsur.2020.05.088","article-title":"Management and long-term outcomes of advanced stage thymoma in the United States","volume":"111","author":"Khorfan","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma: a 13-year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib73","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.bjc.6605347","article-title":"A\u00a0phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)","volume":"101","author":"Kunitoh","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib74","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Eastern Cooperative Oncology Group Phase II Trial. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib77","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib78","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/07357900802563002","article-title":"Prognostic predictors and long-term outcome of postoperative irradiation in thymoma: a study of 241 patients","volume":"27","author":"Wu","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jtho.2022.10.016_bib79","doi-asserted-by":"crossref","first-page":"291","DOI":"10.21037\/gs.2020.03.01","article-title":"Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas","volume":"9","author":"Bian","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1081\/CNV-120023772","article-title":"Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group","volume":"21","author":"Eralp","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jtho.2022.10.016_bib81","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib82","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/09553002.2018.1454618","article-title":"Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988\u20132013)","volume":"94","author":"Mou","year":"2018","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.jtho.2022.10.016_bib83","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cncr.29166","article-title":"Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study","volume":"121","author":"Omasa","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib84","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the International Thymic Malignancies Interest Group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib85","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0003-4975(03)00819-1","article-title":"Comparison of stages I\u2013II thymoma treated by complete resection with or without adjuvant radiation","volume":"76","author":"Singhal","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib86","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.athoracsur.2020.06.078","article-title":"Prognostic factor of completely resected and pathologic T3 N0 M0 thymic epithelial tumor","volume":"111","author":"Tang","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/COC.0000000000000044","article-title":"Adjuvant radiotherapy for stages II and III resected thymoma: A single-institutional experience","volume":"39","author":"Yan","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib88","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/cncr.25851","article-title":"Adjuvant radiotherapy for completely resected stage 2 thymoma","volume":"117","author":"Berman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib89","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.21037\/jtd-2019-thym-09","article-title":"The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature","volume":"12","author":"Bruni","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib90","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ijrobp.2009.09.066","article-title":"Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection","volume":"78","author":"Chen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2007.10.006","article-title":"Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection","volume":"71","author":"D\u2019Angelillo","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1748-717X-8-199","article-title":"Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution","volume":"8","author":"Fan","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00066-014-0740-z","article-title":"Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity","volume":"191","author":"H\u00e4fner","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jtho.2022.10.016_bib94","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ijrobp.2018.07.2022","article-title":"Patterns of failure following postoperative radiation therapy based on \u201ctumor bed with margin\u201d for stage II to IV type C thymic epithelial tumor","volume":"102","author":"Lee","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68168-y","article-title":"Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors","volume":"10","author":"Tomita","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2022.10.016_bib96","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/JTO.0b013e3181e8f345","article-title":"The role of radiation therapy in malignant thymoma: a surveillance, epidemiology, and end results database analysis","volume":"5","author":"Fernandes","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2017.03.020","article-title":"Improved survival with postoperative radiotherapy in thymic carcinoma: a propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database","volume":"108","author":"Lim","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib98","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.21037\/jtd.2016.05.05","article-title":"Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma","volume":"8","author":"Yuan","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib99","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1245\/s10434-008-9984-0","article-title":"Videothoracoscopic resection of encapsulated thymic carcinoma: retrospective comparison of the results between thoracoscopy and open methods","volume":"15","author":"Cheng","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib101","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/1556984520949287","article-title":"Thymic neuroendocrine tumors and thymic carcinoma: demographics, treatment, and survival","volume":"15","author":"Bakhos","year":"2020","journal-title":"Innovations (Phila)"},{"key":"10.1016\/j.jtho.2022.10.016_bib102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ejcts\/ezv239","article-title":"Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese nationwide database study","volume":"49","author":"Hishida","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib103","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jtho.2018.08.005","article-title":"Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort","volume":"13","author":"Merveilleux du Vignaux","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib104","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3892\/ol.2017.6419","article-title":"Prognostic effect of\u00a0class III \u03b2-tubulin and topoisomerase-II in patients\u00a0with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors","volume":"14","author":"Miura","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2022.10.016_bib105","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/JTO.0b013e31822e71c0","article-title":"Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma","volume":"6","author":"Agatsuma","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib106","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1634\/theoncologist.2017-0586","article-title":"Prognostic factors and efficacy of first-line chemotherapy in patients with advanced thymic carcinoma: a retrospective analysis of 286 patients from NEJ023 study","volume":"23","author":"Ko","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.jtho.2022.10.016_bib107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/annonc\/mdu541","article-title":"A\u00a0multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L","volume":"26","author":"Hirai","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib108","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/JTO.0000000000000692","article-title":"A\u00a0prospective phase II study of cisplatin and cremophor EL-free paclitaxel (Genexol-PM) in patients with unresectable thymic epithelial tumors","volume":"10","author":"Kim","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib109","doi-asserted-by":"crossref","first-page":"775","DOI":"10.6061\/clinics\/2015(12)03","article-title":"Chemotherapy and prognosis in advanced thymic carcinoma patients","volume":"70","author":"Song","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jtho.2022.10.016_bib110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1759-7714.12320","article-title":"Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma","volume":"7","author":"Xu","year":"2016","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib111","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/1759-7714.13181","article-title":"Optimal first-line treatment for advanced thymic carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib112","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2019.12.045","article-title":"Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: a prospective phase 2 study","volume":"107","author":"Fan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib113","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1634\/theoncologist.2019-0593","article-title":"Clinical outcomes of second-line chemotherapy in patients with previously treated advanced thymic carcinoma: a retrospective analysis of 191 patients from the NEJ023 study","volume":"25","author":"Tateishi","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jtho.2022.10.016_bib114","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1002\/cam4.3385","article-title":"Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma","volume":"9","author":"Okuma","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtho.2022.10.016_bib115","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.21037\/jtd.2019.06.65","article-title":"S-1 salvage chemotherapy for stage IV thymic carcinoma: A study of 44 cases","volume":"11","author":"Wang","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib116","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial","volume":"37","author":"Cho","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib117","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib118","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib119","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1245\/s10434-015-4825-4","article-title":"Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the Chinese Alliance for Research of thymoma database","volume":"23","author":"Fu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.athoracsur.2019.11.009","article-title":"The role of adjuvant therapy in advanced thymic carcinoma: a national cancer database analysis","volume":"109","author":"Kim","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib121","first-page":"2503","article-title":"Treatment and survival analyses of completely resected thymic carcinoma patients","volume":"8","author":"Mao","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jtho.2022.10.016_bib122","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ejso.2014.05.011","article-title":"Outcomes after surgical resection of thymic carcinoma: a study from a single tertiary referral centre","volume":"40","author":"Song","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib123","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.athoracsur.2018.02.009","article-title":"A\u00a0nomogram predicting recurrence and guiding adjuvant radiation for thymic carcinoma after resection","volume":"106","author":"Wang","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib124","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.athoracsur.2013.04.078","article-title":"Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases","volume":"96","author":"Zhao","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib125","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/1759-7714.12868","article-title":"Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: a propensity-matched study based on the SEER database","volume":"9","author":"Wen","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.10.016_bib126","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ejcts\/ezaa453","article-title":"Clinicopathological features and current treatment outcomes of neuroendocrine thymic tumours","volume":"59","author":"Fang","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib127","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.21037\/jtd.2018.02.82","article-title":"The comparison of predictive factors regarding prognoses and invasion of thymic neuroendocrine tumors preoperatively and postoperatively","volume":"10","author":"Bian","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.10.016_bib128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/icvts\/ivy270","article-title":"Is thymomectomy equivalent to complete thymectomy in non-myasthenic patients with early-stage thymoma?","volume":"28","author":"Fiorelli","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib129","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ejso.2016.03.029","article-title":"Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis","volume":"42","author":"Yang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtho.2022.10.016_bib130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2016.01.007","article-title":"Survival impact of adjuvant radiation therapy in Masaoka stage II to IV thymomas: a systematic review and meta-analysis","volume":"94","author":"Lim","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.10.016_bib131","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2016.12.042","article-title":"A\u00a0meta-analysis of postoperative radiotherapy for thymic carcinoma","volume":"103","author":"Hamaji","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib132","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.athoracsur.2014.12.048","article-title":"A\u00a0meta-analysis of induction therapy for advanced thymic epithelial tumors","volume":"99","author":"Hamaji","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2022.10.016_bib133","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2018.10.018","article-title":"Systemic treatments for thymoma and thymic carcinoma: A systematic review","volume":"126","author":"Berghmans","year":"2018","journal-title":"Lung Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422018779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422018779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:50:38Z","timestamp":1761562238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086422018779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1556086422018779"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2022.10.016","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2022.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}